ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PHVS Pharvaris NV

18.00
-0.10 (-0.55%)
Last Updated: 03:44:01
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Pharvaris NV PHVS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.10 -0.55% 18.00 03:44:01
Open Price Low Price High Price Close Price Previous Close
17.91 17.885 18.39 18.10
more quote information »

Recent News

Date Time Source Heading
11/6/202420:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/6/202420:50GLOBEPharvaris Announces Annual Meeting of Shareholders
05/6/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202420:50GLOBEPharvaris Highlights Properties of Deucrictibant in Data..
25/5/202407:04EDGAR2Form 144 - Report of proposed sale of securities
23/5/202407:54EDGAR2Form 144 - Report of proposed sale of securities
13/5/202420:50GLOBEPharvaris to Present Clinical and Nonclinical Data at..
09/5/202406:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/5/202406:10GLOBEPharvaris Reports First Quarter 2024 Financial Results and..
11/4/202406:10GLOBEPharvaris Reports Fourth Quarter and Full Year 2023..
11/4/202406:08GLOBEPharvaris Appoints David Nassif, J.D., as Chief Financial..
04/4/202421:50GLOBEPharvaris to Present Deucrictibant Clinical Data at the CIIC..
18/3/202421:50GLOBEPharvaris Announces Phase 3 Clinical Study Design for..
12/3/202404:51EDGAR2Form 144 - Report of proposed sale of securities
07/3/202408:40EDGAR2Form F-3ASR - Automatic shelf registration statement of..
07/3/202408:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202422:50GLOBEPharvaris to Present Deucrictibant Clinical Data at Upcoming..
05/3/202422:50GLOBEPharvaris to Participate in the Leerink Global Biopharma..
22/2/202422:50GLOBEPositive Results from CHAPTER-1 Phase 2 Study of..
16/2/202422:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202422:50GLOBEPharvaris Announces Extraordinary Meeting of Shareholders
08/2/202408:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202408:46EDGAR2Form 144 - Report of proposed sale of securities
26/1/202422:50GLOBEPharvaris to Present at the WSAAI Annual Meeting 2024
22/1/202423:35DJNPharvaris Says FDA Lifted Clinical Hold on Application for..
22/1/202422:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202422:50GLOBEPharvaris Announces FDA Lifting of the Clinical Hold of..
08/1/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202422:50GLOBEPharvaris Provides Business Update and Outlines 2024..
03/1/202408:29EDGAR2Form 144 - Report of proposed sale of securities
09/12/202310:00GLOBEPharvaris Presents Deucrictibant Clinical Data and Analysis..
09/12/202308:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202308:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/12/202308:36EDGAR2Form 144 - Report of proposed sale of securities
06/12/202323:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
06/12/202323:02GLOBEPharvaris Announces Pricing of $300 Million Underwritten..
06/12/202322:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202322:50GLOBEPharvaris Announces Positive Top-line Phase 2 Data from the..
30/11/202322:50GLOBEPharvaris to Present at the GA²LEN UCARE Conference 2023
15/11/202322:50GLOBEPharvaris Appoints Stefan Abele, Ph.D., as Chief Technical..
10/11/202303:00GLOBEPharvaris Presents Deucrictibant Clinical Data and..
02/11/202321:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202321:50GLOBEPharvaris Reports Third Quarter 2023 Financial Results and..
30/10/202321:50GLOBEPharvaris To Present at the ACAAI 2023 Annual Scientific..
13/10/202321:50GLOBEPharvaris To Present at the APAAACI 2023 International..
04/10/202322:34GLOBEPharvaris To Present at the CIIC Fall 2023 Conference
20/9/202306:23EDGAR2Form 144 - Report of proposed sale of securities
19/9/202320:50GLOBEPharvaris To Participate in the 2023 Cantor Global..
06/9/202320:51GLOBEPharvaris To Present at the 18th German Allergy Congress
06/9/202320:50GLOBEPharvaris To Participate in the Morgan Stanley 21st Annual..

Your Recent History

Delayed Upgrade Clock